Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
The Long Run with Luke Timmerman - Podcast autorstwa Timmerman Report
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.